DSNKY Daiichi Sankyo Company Limited Sponsored ADRs

Daiichi Sankyo Co., Ltd. engages in the research, development, manufacture, and sale of pharmaceuticals. Its products include drugs for the field of oncology such as Trastuzumab deruxtecan, Anti-HER3-ADC, Quizartinib, Milademetan, Valemetostat, Pexidartinib, Edoxaban, Prasugel, and Microgabalin. The company was founded on September 28, 2005 and is headquartered in Tokyo, Japan. This is an ADR of a company whose stock trades outside of the U.S. as the symbol JT:4568.

This security is traded over-the-counter, or OTC. We don't always have accurate pricing data on OTC stocks.

$35.31    Pink
As of 03/23/2023     OTCMarkets

---

Security Information

---

Category1:  US Equity
Category2:  ADRs
Category3:  Large cap
GICS sector:  Health Care
Industry:  Drug Manufacturers—General
Index country:  Japan
Country of incorporation:  Japan
IPO date:  11/14/2011
Outstanding shares:  1,947,034,029
Average volume:  85,293
Market cap:   $68,749,771,564
Current dividend yield:  0.00%
Sedol:      

---

Valuation   (See tab for details)

---

PE ratio:   0.00
PB ratio:   0.00
PS ratio:   0.00
Return on equity:   0.00%
Net income %:   0.00%